Two new heads at Merck KGaA
This article was originally published in Scrip
Merck KGaA has appointed Friederike Rotsch head of corporate auditing, and Isabel De Paoli head of corporate strategy, both reporting to Karl-Ludwig Kley, chair of the board of directors. Dr Rotsch joined Merck in 2005, and was previously head of corporate legal services. Ms De Paoli joined the company in 2006, transferring to the Merck Serono division in 2009 before being appointed head of global strategic planning oncology.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.